Replies to post #220164 on Biotech Values

[DewDiligence]

AGN receives CRL for Ulipristal treatment for uterine fibroids:

https://www.prnewswire.com/news-releases/allergan-receives-complete-response-letter-from-the-us-food-and-drug-administration-for-ulipristal-acetate-new-drug-application-300700400.html

[DewDiligence]

ABBV/NBIX—FDA approves Oriahnn—(elagolix/estradiol/norethindrone)—for heavy menstrual bleeding from uterine fibroids:

https://www.fda.gov/news-events/press-announcements/fda-approves-new-option-treat-heavy-menstrual-bleeding-associated-fibroids-women

Elagolix monotherapy was FDA-approved in 2018 under the brand name, Orlissa for endometriosis pain (#msg-142416116).